Malignant hyperthermia.
D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D003080:Cold Temperature; D003402:Creatine Kinase / Q000097:blood; D003620:Dantrolene / Q000627:therapeutic use; D004198:Disease Susceptibility; D006801:Humans; D008305:Malignant Hyperthermia / Q000503:physiopathology* / Q000628:therapy; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000378:metabolism*; D011188:Potassium / Q000097:blood; D012519:Sarcoplasmic Reticulum / Q000502:physiology
D002110:Caffeine; D003402:Creatine Kinase; D003620:Dantrolene; D011188:Potassium; D002118:Calcium